siRNA therapy lowers triglycerides in people along with uncommon problem

.STUDY FEATURE.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% and also decreased the danger of pancreatitis in patients along with consistent chylomicronemia, along with or without a genetic diagnosis.